NCT02092935View on ClinicalTrials.gov

A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Clostridium Difficile Infection
Interventions
DRUG

SMT19969

DRUG

Vancomycin

Trial Locations (26)

Unknown

Mobile

Laguna Hills

Long Beach

Sylmar

Ventura

Idaho Falls

Chicago

Topeka

Baltimore

Boston

Detroit

Duluth

Minneapolis

Tupelo

Billings

Butte

Sommers Point

Rochester

Akron

Cincinnati

Columbus

Lima

Rapid City

Seattle

Hamilton

Montreal

Sponsors
All Listed Sponsors
collaborator

Wellcome Trust

OTHER

lead

Summit Therapeutics

INDUSTRY